ESR1 and breast carcinoma: Adjuvant chemotherapy is commonly used to improve survival and to reduce the risk of recurrence in breast cancer patients, particularly in patients with primary tumors that are large, estrogen receptor (ER) negative, high grade, and with lymph nodes involvement [4].